This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GlaxoSmithKline PLC (GSK)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 8.64B 6.75B 9.13B 6.76B
Receivables 8.59B 6.92B 8.71B 8.64B
Inventories 6.99B 6.59B 6.43B 6.41B
Other Current Assets 253.34M 2.03B 257.24M 182.61M
Total Current Assets 24.57B 22.85B 25.11B 22.13B
Property, Plant & Equipment, Gross 14.32B 29.39B 31.09B 30.29B
Accumulated Depreciation & Depletion n.a. 15.30B 16.46B 16.11B
Property, Plant & Equipment, Net 14.32B 14.09B 14.63B 14.18B
Intangibles 24.70B 12.95B 15.31B 16.42B
Other Non-Current Assets 3.63B 3.41B 3.98B 3.40B
Total Non-Current Assets 54.61B 40.43B 44.29B 44.90B
Liabilities & Shareholder Equity
Total Assets 79.18B 63.27B 69.40B 67.02B
Accounts Payable 13.62B 4.81B 8.83B 13.02B
Short Term Debt 1.94B 4.58B 4.60B 5.87B
Other Current Liabilities 4.32B 4.03B 4.24B 3.44B
Total Current Liabilities 19.88B 20.69B 22.55B 22.33B
Long Term Debt 22.70B 24.66B 25.49B 23.71B
Deferred Income Taxes 2.25B 692.63M 1.14B 1.62B
Other Non-Current Liabilities 21.19B 9.55B 7.33B 8.46B
Minority Interest -74.08M 116.74M 316.61M 289.26M
Total Non-Current Liabilities 51.73B 35.94B 35.31B 35.31B
Total Liabilities 71.60B 56.64B 57.86B 57.63B
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 7.58B 6.64B 11.54B 9.39B
Common Par 1.99B 2.08B 2.20B 2.18B
Additional Paid In Capital 4.19B 4.29B 4.28B 3.27B
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings -2.07B -3.23B 1.51B 1.05B
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 3.47B 3.48B 3.55B 2.89B
Total Capitalization 30.28B 31.29B 37.02B 33.10B
Total Equity 7.58B 6.64B 11.54B 9.39B
Total Liabilities & Stock Equity 79.18B 63.27B 69.40B 67.02B
Total Common Shares Outstanding 2.43B 2.68B 2.43B 2.45B
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares 491.52M 491.52M 487.43M 494.95M
Basic Weighted Shares Outstanding 2.42B 2.40B 2.42B 2.46B
Diluted Weighted Shares Outstanding 2.44B 2.43B 2.46B 2.49B
Number of Employees NA 97921 99451 99488
Number of Part-Time Employees NA 0 0 0
GSK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GSK GlaxoSmithKline PLC

Chart of GSK

Analysts Ratings for GSK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 3
Moderate Buy 0 0 0 0
Hold 4 4 4 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET GSK ANALYST REPORT

GSK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs